Role of integrated cancer nanomedicine in overcoming drug resistance

Prospective identification of tumorigenic breast cancer cells

Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579

Stem cells, cancer, and cancer stem cells

Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

Epithelial–mesenchymal transitions in tumour progression

Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565

Multidrug resistance in cancer: role of ATP–dependent transporters

Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552

What Is the Evidence That Tumors Are Angiogenesis Dependent?

Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509

Identification and expansion of human colon-cancer-initiating cells

Ricci‐Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & Maria, R. D. (2006) · Nature · doi:10.1038/nature05384 · Cited by 4,001

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Visvader, J. E., & Lindeman, G. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2499 · Cited by 3,501

Impact of Nanotechnology on Drug Delivery

Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,443

Identification of Pancreatic Cancer Stem Cells

Li, C., Heidt, D. G., Dalerba, P. D., Burant, C., Zhang, L., Adsay, V. N., Wicha, M. S., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,419

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

Panyam, J., & Labhasetwar, V. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,417

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115

Nanoparticles in Medicine: Therapeutic Applications and Developments

Zhang, L., Gu, F., Chan, J. M., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,685

Tumour evolution inferred by single-cell sequencing

Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545

Upconverting Nanoparticles

Haase, M., & Schäfer, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005159 · Cited by 2,541

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495

Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening

Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429

PEGylation, successful approach to drug delivery

Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,344

Chemotherapy and the war on cancer

Chabner, B. A., & Roberts, T. G. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1529 · Cited by 2,231

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P. D., Weissman, I. L., Clarke, M. F., & Ailles, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610117104 · Cited by 2,205

Drug Resistance and the Solid Tumor Microenvironment

Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116

Light-induced shape-memory polymers

Lendlein, A., Jiang, H., Jünger, O., & Langer, R. (2005) · Nature · doi:10.1038/nature03496 · Cited by 2,006

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993

Exploiting the enhanced permeability and retention effect for tumor targeting

Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846

Immunological properties of engineered nanomaterials

Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,706

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: Role and site of cellular reducing activities

Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407

Dendrimers and dendritic polymers in drug delivery

Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,361

The function of sterols in membranes

DEMEL, R. A., & Kruyff, B. D. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(76)90008-3 · Cited by 1,347

Imaging and drug delivery using theranostic nanoparticles

Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,278

Polymerization of oligo(ethylene glycol) (meth)acrylates: Toward new generations of smart biocompatible materials

Lutz, J. (2008) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.22706 · Cited by 1,246

Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells

Liu, S., Dontu, G., Mantle, I. D., Patel, S. H., Ahn, N.-S., Jackson, K. W., Suri, P., & Wicha, M. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0054 · Cited by 1,241

Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery

Du, J., Du, X., Mao, C., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,177

Thermoresponsive Polymers for Biomedical Applications

Ward, M. A., & Georgiou, T. K. (2011) · Polymers · doi:10.3390/polym3031215 · Cited by 1,165

Untitled work

(1996) · PubMed · Cited by 1,141

Stimuli-Responsive Polymersomes for Programmed Drug Delivery

Meng, F., Zhong, Z., & Feijén, J. (2009) · Biomacromolecules · doi:10.1021/bm801127d · Cited by 1,122

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. I. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,095

Combinatorial drug therapy for cancer in the post-genomic era

Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070

Cancer stem cells: mirage or reality?

Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 996

Microbubbles in ultrasound-triggered drug and gene delivery

Hernot, S., & Klibanov, A. L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.005 · Cited by 990

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity

Hope, K. J., Jin, L., & Dick, J. E. (2004) · Nature Immunology · doi:10.1038/ni1080 · Cited by 986

The Promise and Perils of Wnt Signaling Through β-Catenin

Moon, R. T., Bowerman, B. A., Boutros, M., & Perrimon, N. (2002) · Science · doi:10.1126/science.1071549 · Cited by 970

Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism

Mühlen, A. Z., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS

Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 926

Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers

Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 911

RNAi therapeutics: Principles, prospects and challenges

Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 906

Histone Deacetylase Inhibitors in Cancer Therapy

Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 893

Preparation of Ideal PEG Analogues with a Tunable Thermosensitivity by Controlled Radical Copolymerization of 2-(2-Methoxyethoxy)ethyl Methacrylate and Oligo(ethylene glycol) Methacrylate

Lutz, J., & Hoth, A. (2005) · Macromolecules · doi:10.1021/ma0517042 · Cited by 879

Untitled work

(2002) · PubMed · Cited by 840

Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

Sinha, R., Gloria, K., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 802

siRNA vs. shRNA: Similarities and differences

Rao, D. D., Vorhies, J. S., Senzer, N. N., & Nemunaitis, J. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 702

Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers

Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R. M., Mullendore, M. E., Karikari, C. A., Alvarez, H., Iacobuzio–Donahue, C. A., Jimeno, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3281 · Cited by 692

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

Hu, C. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 688

Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis

Grünert, S., Jechlinger, M., & Beug, H. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1175 · Cited by 682

Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer Cells

Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 681

Anthrazykline in der Krebstherapie

Hortobágyi, G. N. (1997) · Drugs · doi:10.2165/00003495-199700544-00003 · Cited by 679

Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer

Wang, Y., Gao, S., Ye, W., Yoon, H. S., & Yang, Y. Y. (2006) · Nature Materials · doi:10.1038/nmat1737 · Cited by 658

The therapeutic promise of the cancer stem cell concept

Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 640

Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves

Meng, H., Xue, M., Xia, T., Zhao, Y., Tamanoi, F., Stoddart, J. F., Zink, J. I., & Nel, A. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104501a · Cited by 611

Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma

Bar, E. E., Chaudhry, A., Lin, A. Y., Fan, X., Schreck, K. C., Matsui, W. H., Piccirillo, S. G. M., Vescovi, A. L., DiMeco, F., Olivi, A., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0166 · Cited by 605

Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example

Torchilin, V. P. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 600

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

Dassie, J. P., Liu, X., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 600

Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 586

Mesenchyme Forkhead 1 ( FOXC2 ) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

Mani, S. A., Yang, J., Brooks, M. W., Schwaninger, G., Zhou, A. Y., Miura, N., Kutok, J. L., Hartwell, K. A., Richardson, A. L., & Weinberg, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703900104 · Cited by 583

Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds

Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 581

Understanding cancer stem cell heterogeneity and plasticity

Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 572

Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting

Li, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 569

Drug Release from Electric-Field-Responsive Nanoparticles

Ge, J., Neofytou, E. A., Cahill, T. J., Beygui, R. E., & Zare, R. N. (2011) · ACS Nano · doi:10.1021/nn203430m · Cited by 534

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 523

Light‐sensitive Intelligent Drug Delivery Systems†

Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519

Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.

Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., & Haga, N. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01345.x · Cited by 502

Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode

Wadhwa, R., Lagenaur, C. F., & Cui, X. T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.027 · Cited by 498

Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect

Dromi, S. A., Frenkel, V., Luk, A., Traughber, B. J., Angstadt, M., Bur, M., Poff, J. A., Xie, J., Libutti, S. K., Li, K. C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2443 · Cited by 494

pH-Responsive Carrier System Based on Carboxylic Acid Modified Mesoporous Silica and Polyelectrolyte for Drug Delivery

Qing, Y., Wang, S., Fan, P., Wang, L., Di, Y., Lin, K., & Xiao, F. (2005) · Chemistry of Materials · doi:10.1021/cm051198v · Cited by 490

Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells

Ganta, S., & Amiji, M. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800240j · Cited by 489

Cancer Stem Cells and Drug Resistance: The Potential of Nanomedicine

Vinogradov, S. V., & Wei, X. (2012) · Nanomedicine · doi:10.2217/nnm.12.22 · Cited by 486

A New Design for Light-Breakable Polymer Micelles

Jiang, J., Tong, X., & Zhao, Y. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0521019 · Cited by 469

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

Sanz, M. Á. (2003) · Blood · doi:10.1182/blood-2003-07-2462 · Cited by 468

pH‐Responsive Supramolecular Nanovalves Based on Cucurbit[6]uril Pseudorotaxanes

Angelos, S., Yang, Y., Patel, K., Stoddart, J. F., & Zink, J. I. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705211 · Cited by 468

Targeting Notch to Target Cancer Stem Cells

Pannuti, A., Foreman, K. E., Rizzo, P., Osipo, C., Golde, T. E., Osborne, B. A., & Miele, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2823 · Cited by 460

Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Manzoor, A. A., Lindner, L. H., Landon, C. D., Park, J. Y., Simnick, A. J., Dreher, M. R., Das, S. K., Hanna, G., Park, W., Chilkoti, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1683 · Cited by 459

Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis

Donnenberg, V. S., & Donnenberg, A. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276905 · Cited by 457

Near-Infrared Light-Triggered Dissociation of Block Copolymer Micelles Using Upconverting Nanoparticles

Yan, B., Boyer, J., Branda, N. R., & Zhao, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja209793b · Cited by 455

Controlled Release of Guest Molecules from Mesoporous Silica Particles Based on a pH‐Responsive Polypseudorotaxane Motif

Park, C., Oh, K., Lee, S. C., & Kim, C. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603404 · Cited by 453

Electrochemically controlled drug delivery based on intrinsically conducting polymers

Svirskis, D. M., Travaš‐Sejdić, J., Rodgers, A., & Garg, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.023 · Cited by 449

Aptamer mediated siRNA delivery

Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 447

Enzymatic reduction of disulfide bonds in lysosomes: Characterization of a Gamma-interferon-inducible lysosomal thiol reductase (GILT)

Arunachalam, B., Phan, U., Geuze, H. J., & Cresswell, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.745 · Cited by 438

Poly(N-isopropylacrylamide-co-propylacrylic acid) Copolymers That Respond Sharply to Temperature and pH

Yin, X., Hoffman, A. S., & Stayton, P. S. (2006) · Biomacromolecules · doi:10.1021/bm0507812 · Cited by 417

Recent advances in shell cross-linked micelles

Read, E. S., & Armes, S. P. (2007) · Chemical Communications · doi:10.1039/b701217a · Cited by 412

Multi-functional nanocarriers to overcome tumor drug resistance

Milane, L. S., van Vlerken, L. E., Yadav, S. K., & Amiji, M. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.04.003 · Cited by 409

Crack Healing in Polymeric Materials via Photochemical [2+2] Cycloaddition

Chung, C., Roh, Y.-S., Cho, S., & Kim, J. (2004) · Chemistry of Materials · doi:10.1021/cm049394+ · Cited by 402

Pharmacological Strategies for Overcoming Multidrug Resistance

Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 395

Toward Photocontrolled Release Using Light-Dissociable Block Copolymer Micelles

Jiang, J., Tong, X., Morris, D., & Zhao, Y. (2006) · Macromolecules · doi:10.1021/ma060142z · Cited by 394

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance

He, Q., Gao, Y., Zhang, L., Zhang, Z., Gao, F., Ji, X., Li, Y., & Shi, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.066 · Cited by 393

Anticancer Therapies Combining Antiangiogenic and Tumor Cell Cytotoxic Effects Reduce the Tumor Stem-Like Cell Fraction in Glioma Xenograft Tumors

Folkins, C., Man, S., Xu, P., Shaked, Y., Hicklin, D. J., & Kerbel, R. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4238 · Cited by 383

Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer

Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 370

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors

Ganesh, S., Iyer, A. K., Morrissey, D. V., & Amiji, M. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.077 · Cited by 361

Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

Steg, A. D., Bevis, K. S., Katre, A. A., Ziebarth, A., Dobbin, Z. C., Alvarez, R. D., Zhang, K., Conner, M. G., & Landen, C. N. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2188 · Cited by 359

Prospects of RNA interference therapy for cancer

Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T. ‐. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352

Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer

Delbaldo, C., Michiels, S., Syz, N., Soria, J., Chevalier, T. L., & Pignon, J. (2004) · JAMA · doi:10.1001/jama.292.4.470 · Cited by 343

Chemotherapy-induced resistance by ATP-binding cassette transporter genes

Gillet, J. A., Efferth, T., & Remacle, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 342

Polymer Micelles Stabilization on Demand through Reversible Photo-Cross-Linking

Jiang, J., Qi, B., Lepage, M., & Zhao, Y. (2007) · Macromolecules · doi:10.1021/ma062493j · Cited by 340

TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors

Sethuraman, V. A., & Bae, Y. H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.008 · Cited by 338

Notch and cancer: a double-edged sword

Koch, U., & Radtke, F. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7164-1 · Cited by 337

Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database

Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 331

Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound

Gao, Z., Fain, H. D., & Rapoport, N. Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.021 · Cited by 328

Electrically Controlled Drug Delivery from Biotin‐Doped Conductive Polypyrrole

George, P. M., LaVan, D. A., Burdick, J. A., Chen, C. ‐., Liang, E., & Langer, R. (2006) · Advanced Materials · doi:10.1002/adma.200501242 · Cited by 320

Magnetic field triggered drug release from polymersomes for cancer therapeutics

Oliveira, H., Pérez-Andrés, E., Thévenot, J., Sandre, O., Berra, E., & Lecommandoux, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.013 · Cited by 310

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance

Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 308

Macromolecular Therapeutics

Greish, K. F., Fang, J. Q., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278

Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery

Yoo, J., Doshi, N., & Mitragotri, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.004 · Cited by 277

Magnetothermally-responsive Nanomaterials: Combining Magnetic Nanostructures and Thermally-Sensitive Polymers for Triggered Drug Release

Brazel, C. S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9773-2 · Cited by 264

Frontiers in cancer nanomedicine: directing mass transport through biological barriers

Mauro Ferrari, B. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 261

Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies

Wu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874467210801020093 · Cited by 257

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives

Saunders, N. A., Simpson, F., Thompson, E. W., Hill, M. M. C., Endo‐Munoz, L., Leggatt, G. R., Minchin, R. F., & Guminski, A. D. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101131 · Cited by 252

Development of Novel Combination Therapies

Woodcock, J., Griffin, J. P., & Behrman, R. E. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1101548 · Cited by 248

Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies

Shenoy, D. B., Little, S. R., Langer, R., & Amiji, M. M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8343-0 · Cited by 246

Polymer-Caged Lipsomes: A pH-Responsive Delivery System with High Stability

Lee, S., Chen, H., Dettmer, C. M., O’Halloran, T. V., & Nguyen, S. T. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070748i · Cited by 245

Gene expression control by temperature with thermo-responsive polymeric gene carriers

Kurisawa, M., Yokoyama, M., & Okano, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00297-2 · Cited by 237

Organelle-Targeted Nanocarriers: Specific Delivery of Liposomal Ceramide to Mitochondria Enhances Its Cytotoxicity in Vitro and in Vivo

Boddapati, S. V., D’Souza, G. G. M., Erdoğan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 236

Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress

Marcucci, F., & Lefoulon, F. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02988-x · Cited by 235

Coil-globule transition of poly(N-isopropylacrylamide): a study of surfactant effects by light scattering

Meewes, M., Rička, J., Silva, M. D., Nyffenegger, R. M., & Binkert, T. (1991) · Macromolecules · doi:10.1021/ma00021a014 · Cited by 235

Factors affecting acoustically triggered release of drugs from polymeric micelles

Husseini, G. A., Myrup, G. D., Pitt, W. G., Christensen, D. A., & Rapoport, N. Y. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00278-9 · Cited by 230

Acoustically-active microbubbles conjugated to liposomes: Characterization of a proposed drug delivery vehicle

Kheirolomoom, A., Dayton, P. A., Lum, A. F. H., Little, E. L., Paoli, E. E., Zheng, H., & Ferrara, K. W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.015 · Cited by 225

Preparation and Evaluation of Thiol-Modified Gelatin Nanoparticles for Intracellular DNA Delivery in Response to Glutathione

Kommareddy, S., & Amiji, M. M. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050146t · Cited by 220

Side Population Cells Isolated from Mesenchymal Neoplasms Have Tumor Initiating Potential

Wu, C., Wei, Q., Utomo, V., Nadesan, P., Whetstone, H., Kandel, R. A., Wunder, J. S., & Alman, B. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0999 · Cited by 220

Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia

Li, L., ten Hagen, T. L. M., Schipper, D., Wijnberg, T. M., van Rhoon, G. C., Eggermont, A. M. M., Lindner, L. H., & Koning, G. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.006 · Cited by 215

Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer

van Vlerken, L. E., Duan, Z., Seiden, M. V., & Amiji, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1648 · Cited by 214

Drug delivery in pluronic micelles: Effect of high-frequency ultrasound on drug release from micelles and intracellular uptake

Marin, A., Sun, H., Husseini, G. A., Pitt, W. G., Christensen, D. A., & Rapoport, N. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00262-6 · Cited by 213

Looking ahead in cancer stem cell research

Dick, J. E. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-44 · Cited by 212

Is Tumor Growth Sustained by Rare Cancer Stem Cells or Dominant Clones?

Adams, J. M., & Strasser, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6334 · Cited by 210

Thermoresponsive core–shell magnetic nanoparticles for combined modalities of cancer therapy

Purushotham, S., Chang, J. P.-E., Rumpel, H., Kee, I. H. C., Ng, R. T. H., Chow, P. K. H., Tan, C., & Ramanujan, R. V. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/30/305101 · Cited by 201

Enhancement of the Phase Transition Permeability of DPPC Liposomes by Incorporation of MPPC: A New Temperature-Sensitive Liposome for use with Mild Hyperthermia

Anyarambhatla, G., & Needham, D. (1999) · Journal of Liposome Research · doi:10.3109/08982109909035549 · Cited by 200

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

Witta, S. E., Jotte, R. M., Konduri, K., Neubauer, M., Spira, A. I., Ruxer, R. L., Varella‐Garcia, M., Bunn, P. A., & Hirsch, F. R. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9411 · Cited by 198

Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia

Li, L., ten Hagen, T. L. M., Bolkestein, M., Gasselhuber, A., Yatvin, J., van Rhoon, G. C., Eggermont, A. M. M., Haemmerich, D., & Koning, G. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.026 · Cited by 196

Poly(ethylene oxide)-Modified Poly(β-amino ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs. 1. In Vitro Evaluations

Shenoy, D. B., Little, S. R., Langer, R., & Amiji, M. M. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500420 · Cited by 193

Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology

Chen, S., Ding, J.-H., Bekeredjian, R., Yang, B.-Z., Shohet, R. V., Johnston, S. A., Hohmeier, H. E., Newgard, C. B., & Grayburn, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602921103 · Cited by 189

Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier

Kaneshiro, T. L., & Lu, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.026 · Cited by 186

Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.

Huang, S. K., Stauffer, P. R., Hong, K., Guo, J., Phillips, T. L., Huang, A., & Papahadjopoulos, D. (1994) · PubMed · Cited by 183

Fast Photodegradable Block Copolymer Micelles for Burst Release

Han, D., Tong, X., & Zhao, Y. (2011) · Macromolecules · doi:10.1021/ma102778d · Cited by 183

Arginine functionalized peptide dendrimers as potential gene delivery vehicles

Luo, K., Li, C., Li, L., She, W., Wang, G., & Gu, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.030 · Cited by 181

Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer

Di Maio, M., Chiodini, P., Georgoulias, V., Hatzidaki, D., Takeda, K., Wachters, F. M., Gebbia, V., Smit, E. F., Morabito, A., Gallo, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5844 · Cited by 181

Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis

Werner, M. E., Karve, S., Sukumar, R., Cummings, N. D., Copp, J. A., Chen, R. C., Zhang, T., & Wang, A. Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.067 · Cited by 176

Multi-functional nanocarriers for targeted delivery of drugs and genes

Milane, L. S., van Vlerken, L. E., Devalapally, H., Shenoy, D. B., Kommareddy, S., Bhavsar, M. D., & Amiji, M. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.016 · Cited by 172

Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.

Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 172

Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy

Kono, K., Ozawa, T., Yoshida, T., Ozaki, F., Ishizaka, Y., Maruyama, K., Kojima, C., Harada, A., & Aoshima, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.045 · Cited by 168

Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells

Milane, L. S., Duan, Z., & Amiji, M. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 165

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma

Susa, M., Iyer, A. K., Ryu, K., Hornicek, F. J., Mankin, H. J., Amiji, M. M., & Duan, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-399 · Cited by 162

Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?

Deonarain, M. P., Kousparou, C. A., & Epenetos, A. A. (2009) · mAbs · doi:10.4161/mabs.1.1.7347 · Cited by 160

Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS)

Bhavsar, M. D., & Amiji, M. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.006 · Cited by 159

Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from the p-Glycoprotein (ABCB1) Modulator Tariquidar

Kühnle, M., Egger, M. E., Müller, C., Mahringer, A., Bernhardt, G., Fricker, G., König, B., & Buschauer, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013822 · Cited by 158

Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma

Susa, M., Iyer, A. K., Ryu, K., Choy, E., Hornicek, F. J., Mankin, H. J., Milane, L. S., Amiji, M. M., & Duan, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010764 · Cited by 157

Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model

Devalapally, H., Shenoy, D. B., Little, S. R., Langer, R., & Amiji, M. M. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0287-5 · Cited by 155

Photoresponsive Properties of Poly(N-isopropylacrylamide) Hydrogel Partly Modified with Spirobenzopyran

Sumaru, K., Ohi, K., Takagi, T., Kanamori, T., & Shinbo, T. (2006) · Langmuir · doi:10.1021/la052899+ · Cited by 150

Controlled Pulsatile Drug Release from a Ferrogel by a High-Frequency Magnetic Field

Hu, S., Liu, T., Liu, D., & Chen, S. (2007) · Macromolecules · doi:10.1021/ma0707584 · Cited by 146

Poly(ethylene glycol)–modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery

Kommareddy, S., & Amiji, M. M. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.11.005 · Cited by 144

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling

Chen, H., Li, H., Li, J., Zhu, Z. G., Yin, S., Hao, X., Yao, M., Zheng, S.-S., & Gu, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn223 · Cited by 142

Synthesis of Novel Biodegradable Thermoresponsive Triblock Copolymers Based on Poly[(R)-3-hydroxybutyrate] and Poly(N-isopropylacrylamide) and Their Formation of Thermoresponsive Micelles

Loh, X. J., Zhang, Z., Wu, Y., Lee, T. S., & Li, J. (2008) · Macromolecules · doi:10.1021/ma8019865 · Cited by 141

Biodistribution and Pharmacokinetic Analysis of Long-Circulating Thiolated Gelatin Nanoparticles Following Systemic Administration in Breast Cancer-Bearing Mice

Kommareddy, S., & Amiji, M. M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20813 · Cited by 139

Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo

Obata, Y., Tajima, S., & Takeoka, S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.023 · Cited by 138

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

Ganesh, S., Iyer, A. K., Weiler, J., Morrissey, D. V., & Amiji, M. M. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.29 · Cited by 136

The tumor microenvironment controls drug sensitivity

Östman, A. (2012) · Nature Medicine · doi:10.1038/nm.2938 · Cited by 135

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels

Hallahan, D. E., Geng, L., Qu, S., Scarfone, C., Giorgio, T. D., Donnelly, E. F., Gao, X., & Clanton, J. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00238-6 · Cited by 134

Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer

Hua, M., Yang, H., Chuang, C., Tsai, R., Chen, W.-J., Chuang, K., Chang, Y., Chuang, H., & Pang, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.061 · Cited by 130

Expression of Multidrug Resistance Genes in Normal and Cancer Stem Cells

Shervington, A. A., & Lu, C. (2008) · Cancer Investigation · doi:10.1080/07357900801904140 · Cited by 129

Core/Single‐Crystal‐Shell Nanospheres for Controlled Drug Release via a Magnetically Triggered Rupturing Mechanism

Hu, S., Chen, S., Liu, D., & Hsiao, C.-S. (2008) · Advanced Materials · doi:10.1002/adma.200800193 · Cited by 128

Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer

Arrieta, O. G., la Rosa, C. H. G.-D., Aréchaga-Ocampo, E., Villanueva-Rodríguez, G., Cerón-Lizárraga, T., Martínez-Barrera, L. M., Vázquez-Manríquez, M. E., Ríos-Trejo, M. Á., Álvarez-Avitia, M. Á., Hernández‐Pedro, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6452 · Cited by 128

Intracellular Uptake and Trafficking of Pluronic Micelles in Drug‐Sensitive and MDR Cells: Effect on the Intracellular Drug Localization

Rapoport, N. Y., Marin, A., Luo, Y., Prestwich, G. D., & Muniruzzaman, M. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10006 · Cited by 128

Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology

Milane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128

A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells

Yavlovich, A., Singh, A., Blumenthal, R. P., & Puri, A. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.07.030 · Cited by 127

ABC transporters and their role in nucleoside and nucleotide drug resistance

Fukuda, Y., & Schuetz, J. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.042 · Cited by 126

Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.

Ganta, S., Devalapally, H., & Amiji, M. (2010) · Journal of Pharmacy and Science · doi:10.1002/jps.22157 · Cited by 125

Modular Synthesis of Biodegradable Diblock Copolymers for Designing Functional Polymersomes

Katz, J. S., Zhong, S., Ricart, B. G., Pochan, D. J., Hammer, D. A., & Burdick, J. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910606y · Cited by 123

Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy

Kono, K., Nakashima, S., Kokuryo, D., Aoki, I., Shimomoto, H., Aoshima, S., Maruyama, K., Yuba, E., Kojima, C., Harada, A., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.050 · Cited by 123

Anti-DLL4 Inhibits Growth and Reduces Tumor-Initiating Cell Frequency in Colorectal Tumors with Oncogenic KRAS Mutations

Fischer, M. M., Yen, W.-C., Kapoun, A. M., Wang, M., O’Young, G., Lewicki, J. A., Gurney, A. L., & Hoey, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2817 · Cited by 123

Peptide dendrimers as efficient and biocompatible gene delivery vectors: Synthesis and in vitro characterization

Luo, K., Li, C., Wang, G., Nie, Y., He, B., Wu, Y., & Gu, Z. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.006 · Cited by 122

Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers

Gao, Z., Fain, H. D., & Rapoport, N. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049958h · Cited by 121

Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning

Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-3 · Cited by 120

Combinatorial-Designed Multifunctional Polymeric Nanosystems for Tumor-Targeted Therapeutic Delivery

Abeylath, S. C., Ganta, S., Iyer, A. K., & Amiji, M. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000106 · Cited by 119

Poly(amidoamine)s as Potential Endosomolytic Polymers: EvaluationIn Vitroand Body Distribution in Normal and Tumour-Bearing Animals

Richardson, S. C. W., Ferruti, P., & Duncan, R. (1999) · Journal of drug targeting · doi:10.3109/10611869908996846 · Cited by 116

Acoustic activation of drug delivery from polymeric micelles: effect of pulsed ultrasound

Marin, A., Muniruzzaman, M., & Rapoport, N. Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00216-4 · Cited by 112

Drug release characteristics of physically cross‐linked thermosensitive poly(N‐vinylcaprolactam) hydrogel particles

Vihola, H., Laukkanen, A., Tenhu, H. J., & Hirvonen, J. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21348 · Cited by 111

Paclitaxel and ceramide co‐administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer

Devalapally, H., Duan, Z., Seiden, M. V., & Amiji, M. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22886 · Cited by 110

A Novel Controlled Release Drug Delivery System for Multiple Drugs Based on Electrospun Nanofibers Containing Nanoparticles

Wang, Y., Wang, B., Qiao, W., & Yin, T. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22189 · Cited by 110

Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers

Xu, Q., Wang, C., & Pack, D. W. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920469 · Cited by 109

Receptor-Mediated Gene Delivery Using PAMAM Dendrimers Conjugated with Peptides Recognized by Mesenchymal Stem Cells

Santos, J. L., Pandita, D., Rodrigues, J., Pêgo, A. P., Granja, P. L., Balian, G., & Tomás, H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002877 · Cited by 108

Deep local hyperthermia for cancer therapy: external electromagnetic and ultrasound techniques.

Cheung, A. Y., & Neyzari, A. (1984) · PubMed · Cited by 105

Synthesis and Characterization of Injectable, Thermally and Chemically Gelable, Amphiphilic Poly(N-isopropylacrylamide)-Based Macromers

Hacker, M. C., Klouda, L., Ma, B. B., Kretlow, J. D., & Mikos, A. G. (2008) · Biomacromolecules · doi:10.1021/bm8000414 · Cited by 104

Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer

Verma, A. K., Guha, S., Diagaradjane, P., Kunnumakkara, A. B., Sanguino, A. M., Lopez‐Berestein, G., Sood, A. K., Aggarwal, B. B., Krishnan, S., Gelovani, J. G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4529 · Cited by 101

Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters)

Yin, Q., Shen, J., Chen, L., Zhang, Z., Gu, W., & Li, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.039 · Cited by 100

Cancer nanomedicine: from targeted delivery to combination therapy

Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693

Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine

Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597

Nanoparticles in Drug Delivery: From History to Therapeutic Applications

Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468

Cancer stem cell (CSC) resistance drivers

Najafi, M., Mortezaee, K., & Majidpoor, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116781 · Cited by 485

Biological agents for synthesis of nanoparticles and their applications

Pandit, C., Roy, A., Ghotekar, S. K., Khusro, A., Islam, M. N., Emran, T. B., Lam, S. E., Khandaker, M. U., & Bradley, D. A. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.101869 · Cited by 454

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy

Liu, S., Khan, A. R., Yang, X., Dong, B., Ji, J., & Zhai, G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.012 · Cited by 142

Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective

Ahmad, J., Akhter, S., Khan, M. A., Wahajuddin, M., Greig, N. H., Kamal, M. A., Midoux, P., & Pichon, C. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160617112111 · Cited by 57

Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives

Chistiakov, D. A., Myasoedova, V. A., Orekhov, A. N., & Bobryshev, Y. V. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170407123941 · Cited by 11

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

Yadav, P., Ambudkar, S. V., & Prasad, N. R. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01626-z · Cited by 109

Integrating Nanotechnology in Cancer Treatment: Drug Targeting, Multidrug Resistance (MDR) Mechanisms, Therapeutic Strategies and Future Perspectives

S.*, R. V. K. A. (2026) · Journal of Pharmaceutical Sciences · doi:10.5281/zenodo.20844658